Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.
Press releases published on June 26, 2025
Skyharbour’s JV Partner Orano Commences 6-7,000m Summer Drilling Program at the Preston Uranium Project
GlobeNewswire
·
June 26, 2025
Vancouver, BC, June 26, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that its joint-venture partner, Orano Canada Inc. (“Orano”), recently commenced …
BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET
GlobeNewswire
·
June 26, 2025
PALO ALTO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on …
Dynacor Group Declares July 2025 Dividend
GlobeNewswire
·
June 26, 2025
MONTREAL, June 26, 2025 (GLOBE NEWSWIRE) -- Dynacor Group Inc. (TSX: DNG) ("Dynacor" or the "Corporation") announced its monthly dividend payment for July 2025 in the amount of C$0.01333 per common share, which will be payable on July 17, 2025, to …
Groupe Dynacor déclare son dividende pour juillet 2025
GlobeNewswire
·
June 26, 2025
MONTRÉAL, 26 juin 2025 (GLOBE NEWSWIRE) -- Groupe Dynacor Inc. (TSX : DNG) (« Dynacor » ou la « Société ») a le plaisir d’annoncer la déclaration de son dividende mensuel pour le mois de juillet 2025 au montant de 0,01333 $CA par action qui sera payé le 17 …
Invivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infection
GlobeNewswire
·
June 26, 2025
Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events (AEs) deemed unrelated or classified as mild to moderate and largely related to injection site and infusion …
NexGold Infill Drilling Continues to Intersect High Grade Gold Mineralization at the Goldboro Gold Project; 3.58 g/t Gold Over 18.3 Metres, 2.79 g/t gold over 19.7 Metres and 103.50 g/t Gold Over 0.7 Metres
GlobeNewswire
·
June 26, 2025
TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide a further update on its ongoing 25,000-metre diamond drill program initially announced on January 22, 2025 at the …
Aya Gold & Silver Launches Drill Exploration Program at Zgounder Far East and Adds 6 New Regional Permits
GlobeNewswire
·
June 26, 2025
MONTREAL, June 26, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce high-grade silver results from its ongoing drill exploration program at the Zgounder Silver Mine and the start …
XORTX Announces USD $925,000 Private Placement
GlobeNewswire
·
June 26, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 26, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late …
Erdene Announces Results of Annual and Special Meeting of Shareholders
GlobeNewswire
·
June 26, 2025
HALIFAX, Nova Scotia, June 26, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corporation (TSX:ERD | MSE:ERDN) (“Erdene” or the “Company”) is pleased to announce its shareholders voted in favour of all items of business brought before them at the …
Medicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
GlobeNewswire
·
June 26, 2025
Updated cash guidance provides runway into at least mid-2026 MDNA11 Phase 1/2 clinical trial on track for data readouts in second half of the year as a single agent and in combination with KEYTRUDA® at medical conferences and a planned KOL event MDNA11 …
Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH
GlobeNewswire
·
June 26, 2025
First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with statistically significant MASH resolution without worsening of fibrosis in up to 59.1% of participants in an ITT analysis …
Altcoin Season Officially Begins With Bitcoin Solaris: The Bitcoin Alternative Creating a New Wealthy Class
GlobeNewswire
·
June 26, 2025
TALLINN, Estonia, June 26, 2025 (GLOBE NEWSWIRE) -- crypto world has seen its fair share of trends, seasons, and tokens that promised to change the financial landscape. But this time, something feels different. Investors are not just chasing hype. They’re …